Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1995
10/19/1995WO1995027706A1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof
10/19/1995WO1995027511A1 NEW COMBINATION OF A β-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC
10/19/1995WO1995027502A1 Method of treating auto-immune diseases using type one interferons
10/19/1995WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027495A2 Treatment of partial growth hormone insensitivity syndrome
10/19/1995WO1995027490A1 Use of serotonin antagonists (5ht3) for treating fibromyalgia
10/19/1995WO1995027485A1 Methods of using iron chelating compounds to reduce free radical damage in mammals
10/19/1995WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187550A1 Method of treating auto-immune diseases using type one interferons
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/18/1995EP0677516A1 Cyclic amide derivatives
10/18/1995EP0677106A1 Leukocyte derived growth factors
10/18/1995EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677042A1 Selective ligands of receptors 5-ht 1d?-5ht 1b? derived from indole-piperazine useful as medicaments
10/18/1995EP0677039A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
10/18/1995EP0676960A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors
10/18/1995EP0676959A1 Endothelin receptor antagonists
10/18/1995EP0676951A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/17/1995US5459270 Tachykinin antagonist for central nervous systum disorders and cardiovascular disorders
10/17/1995US5459156 Angiotensin converting enzyme inhibitors, hypotensive, atherosclerosis
10/17/1995US5459152 Platelet activating factor antagonists
10/17/1995US5459151 N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
10/17/1995US5459150 Treatment of allergies and inflammatory diseases
10/17/1995US5459148 Cardiovascular disorders
10/17/1995US5459147 Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma
10/17/1995US5459135 Administer synergistic amounts of dedimethylaminotetracycline and indomethacin
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995CA2048894C Method of treating mast cell disease
10/17/1995CA2001671C Aqueous elcatonin solution composition
10/17/1995CA1337352C Substituted propane-phosphinic acid compounds
10/17/1995CA1337347C Benzimidazoline-2-one-1-carboxylic acid derivatives useful as 5-ht receptor antagonists
10/12/1995WO1995027202A1 Screening method using the rzr receptor family
10/12/1995WO1995027062A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027055A1 α-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY
10/12/1995WO1995027052A1 Human interleukin variants generated by alternative splicing
10/12/1995WO1995027045A1 The isolation and production of catalytic antibodies using phage technology
10/12/1995WO1995026984A1 Process for producing composition containing bovine insulin-like growth factor 1
10/12/1995WO1995026960A1 Physiologically active substance ei-1507
10/12/1995WO1995026958A1 Pyrimidinyl derivatives as interleukin inhibitors
10/12/1995WO1995026957A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
10/12/1995WO1995026746A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/12/1995WO1995026743A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995WO1995026739A2 Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions
10/12/1995WO1995026738A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995WO1995026737A1 Use of biopolymers for digestive tract injuries treatment
10/12/1995WO1995026725A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction
10/12/1995WO1995026723A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995WO1995025091A3 Nipecotic acid derivatives as antithrombic compounds
10/12/1995CA2563203A1 Prevention and treatment of ischemia-reperfusion and endotoxin-related injury using adenosine and purino receptor antagonists
10/12/1995CA2187200A1 Nadh oxidase as a target in diagnosis and therapy
10/12/1995CA2187166A1 Novel substituted tryptamines, phenalkylamines and related compounds
10/12/1995CA2186908A1 .alpha.-1-antichymotrypsin analogues having elastase inhibitory activity
10/12/1995CA2186854A1 Human interleukin variants generated by alternative splicing
10/12/1995CA2186783A1 Pharmaceutical preparations and medicinal substances for the prevention and treatment of endothelial dysfunctions
10/12/1995CA2186758A1 Use of growth factor protecting polymers for treating inflammation
10/12/1995CA2185211A1 Agonist antibodies against the flk2/flt3 receptor and uses thereof
10/12/1995CA2182700A1 Screening method using the rzr receptor family
10/11/1995EP0676413A2 Interferon-alpha/beta binding protein, its preparation and use
10/11/1995EP0676396A1 Tetrazolylphenyl pivalate derivatives and medicinal composition containing the same as effective component
10/11/1995EP0676203A1 Pharmaceutical compositions of antiglucocorticoid compounds for treating or preventing symptoms of spontaneous or narcotic-induced withdrawal
10/11/1995EP0676201A2 Use of a riminophenazine for treating MDR resistance
10/11/1995EP0676200A2 Use of eliprodil and of its enantiomers in the preparation of medicaments for the treatment of peripheral neuropathies and or central neurodegenerative diseases
10/11/1995EP0676198A1 Fungicidal compositions containing a combination of bifonazole and fluocinonide
10/11/1995EP0675900A1 Antibiotics ge 37468 a, b and c
10/11/1995EP0675896A1 Purine derivatives
10/11/1995EP0675888A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor
10/11/1995EP0675886A1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
10/11/1995EP0675735A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof
10/11/1995EP0675730A1 Therapeutic combination containing interferon
10/11/1995EP0675728A1 Products and methods for improving keratinocyte adhesion to the dermis
10/11/1995EP0675723A1 Bisphosphonate/estrogen therapy for treating and preventing bone loss
10/11/1995EP0675719A1 Novel combination of benzoquinazoline antifolates and protecting agents
10/11/1995EP0675718A1 Substituted pyridyl compounds useful as leukotriene antagonists
10/11/1995EP0675715A1 Cell differentiation induction with mevalonate and mevalonolactone derivatives
10/11/1995EP0675714A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A $g(b)-LACTAM CHOLESTEROL ABSORPTION INHIBITOR
10/11/1995EP0675713A1 Use of prodelphinidines for treating ostearthritis
10/11/1995EP0675712A1 Reduction of hair growth employing sulfhydryl reactive compounds
10/11/1995EP0538330B1 Beta-alethine use in cell culture and therapy
10/11/1995EP0440704B1 Compositions for treating tobacco withdrawel symptoms
10/11/1995CN1109884A Methods of inhibiting myeloperoxidase activity
10/11/1995CN1109872A Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations b ased on these compounds
10/11/1995CN1109751A Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
10/11/1995CN1029964C Novel N-(4-piperidinyl) bicyclic condensed 2-imiolazolamine derivatives
10/10/1995US5457237 Used in treating cancer and-or atherosclerosis
10/10/1995US5457209 4-[α(cyanophenyl)-1-(1,2,3-triazolyl)methyl]-benzonitrile
10/10/1995US5457183 Radiosensitizers
10/10/1995US5457129 Inhibition of nitric oxide production by retinoic acid
10/10/1995US5457125 Oxime derivatives
10/10/1995US5457118 Pyridine derived agents for cardiovascular diseases
10/10/1995US5457117 Method for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[B][2-(piperidin-1-yl)ethoxyphenylimethanone hydrochloride
10/10/1995US5457109 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
1 ... 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 ... 1564